Steven Cohen Cure Vac N.V. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Cure Vac N.V. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,422,728 shares of CVAC stock, worth $8.33 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,422,728
Previous 2,422,728
-0.0%
Holding current value
$8.33 Million
Previous $8.24 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CVAC
# of Institutions
99Shares Held
14.4MCall Options Held
241KPut Options Held
419K-
Israel Englander Millennium Management LLC | New York, Ny2.87MShares$9.88 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$7.75 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.6MShares$5.5 Million9.09% of portfolio
-
Camber Capital Management LP Boston, MA550KShares$1.89 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY395KShares$1.36 Million0.0% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $645M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...